BioSerenity experimented 5G!
Line of business
- HD video connection with the practitioner .
- Fine frequency synchronization of video and data streams.
5G: The number one ally of telemedicine
BioSerenity is a telemedicine expert company that develops connected medical devices. Its ambition? To connect patients with their healthcare professionals, regardless of the time and place. In juin 2021, it became the telemedicine winner of the 5G challenge organized by the city of Issy-les-Moulineaux and Orange 5G Lab. Its new device, called Neuronaute, is as ambitious as it is adapted to the strong needs of medical monitoring outside the hospital setting. EHPAD in the lead, have had to juggle between the medical care of their residents, social distancing, and health security since the beginning of COVID-19.
The BioSerenity’s concept? A medical device that is easy to install and use, associated with a Cloud platform that allows EEG (electroencephalogram test) to be performed outside the hospital without losing the expertise. A first of its kind that could well improve patient monitoring and relieve some of the congestion in hospitals. The only condition is to have an instantaneous broadband connection anywhere. This is why BioSerenity wanted to test its device – which is still under development – on a network such as 5G.
A few months of collaboration with the Orange 5G Lab team allowed BioSerenity to verify the benefits of 5G and refine their use case. In particular, thanks to a real-life experiment in an EHPAD. Here’s an overview with a joint interview with Pierre Prot, Project Manager at BioSerenity, and Jean-Pierre Casara, head of the 5G Lab program.